Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Fish and Richardson
Cantor Fitzgerald
US Department of Justice
Moodys
Farmers Insurance
McKesson
Argus Health

Generated: August 19, 2018

DrugPatentWatch Database Preview

Diatrizoate meglumine; diatrizoate sodium - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for diatrizoate meglumine; diatrizoate sodium and what is the scope of diatrizoate meglumine; diatrizoate sodium freedom to operate?

Diatrizoate meglumine; diatrizoate sodium is the generic ingredient in seventeen branded drugs marketed by Bayer Hlthcare, Intl Medication, Ge Healthcare, Mallinckrodt, Liebel-flarsheim, and Bracco, and is included in thirteen NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for diatrizoate meglumine; diatrizoate sodium. Three suppliers are listed for this compound.

Summary for diatrizoate meglumine; diatrizoate sodium
US Patents:0
Tradenames:17
Applicants:6
NDAs:13
Drug Master File Entries: 9
Suppliers / Packagers: 3
DailyMed Link:diatrizoate meglumine; diatrizoate sodium at DailyMed
Pharmacology for diatrizoate meglumine; diatrizoate sodium

US Patents and Regulatory Information for diatrizoate meglumine; diatrizoate sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco RENOGRAFIN-60 diatrizoate meglumine; diatrizoate sodium INJECTABLE;INJECTION 010040-006 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bracco RENOVIST diatrizoate meglumine; diatrizoate sodium INJECTABLE;INJECTION 010040-020 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mallinckrodt MD-76 diatrizoate meglumine; diatrizoate sodium INJECTABLE;INJECTION 087073-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bayer Hlthcare ANGIOVIST 370 diatrizoate meglumine; diatrizoate sodium INJECTABLE;INJECTION 087723-001 Sep 23, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Moodys
US Department of Justice
Cipla
Daiichi Sankyo
Argus Health
Deloitte
Farmers Insurance
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.